Sort by
Refine Your Search
-
Institute), we aim to understand how leukemic cells that survive chemotherapy (persisters) evade T-cell recognition and contribute to disease relapse. We will study both the landscape of MHC-I peptides
-
Validation of novel molecular targets from anti-inflammatory and cytoprotective molecules in neurons
targets through the investigation of anti-inflammatory peptides derived from animal venoms. The activities involve elucidating the peptide effects in cell culture, and in vivo using inflammatory and pain
-
targets through the investigation of anti-inflammatory peptides derived from animal venoms. The activities involve elucidating the peptide effects in cell culture, and in vivo using inflammatory and pain
-
computational framework that will enable a rational design of peptide-based materials used in emerging technologies ranging from drug delivery to soft semiconductor devices. For more information, visit our
-
for molecular and cellular biology, immunoassays, protein analyses and BSL2/BLS3 cell culture are available.Eligibility criteria1.The researcher must be in possession of a doctoral degree or have successfully
-
Italy | 26 days ago
income countries are ongoing, with infield activities. Cutting-edge equipment for molecular and cellular biology, immunoassays, protein analyses and BSL2/BLS3 cell culture are available.Eligibility
-
-engineering, or equivalent. Required proven expertise in: live cell imaging, cloning (e.g. Golden Gate, Gibson), protein biochemistry, guidance of master and/or PhD students. Desired expertise in: interactomics
-
for resonance assignment in protein applications, with gains on the order of x2-3 per transfer (Tošner et al., 2018; Blahut et al., 2022, 2023). We are looking for postdoctoral fellows and PhD candidates to carry